Franch A, Castellote C, Castell M
Unit of Physiology, Faculty of Pharmacy, University of Barcelona, Spain.
Rheumatol Int. 1994;14(1):27-31. doi: 10.1007/BF00302668.
The production of antibodies to IgG and type II collagen occurs in a similar fashion in human rheumatoid arthritis and adjuvant arthritis. In this study, the effect of dexamethasone (DXT) and acetylsalicylic acid (ASA) on antibody synthesis was analysed. Daily treatment with DXT (0.3 mg/kg per day p.o.) or with ASA (200 mg/kg per day p.o.) from day 14 to day 56 after arthritis induction inhibited both the synthesis of antibodies to IgG and type II collagen and also the humoral immune response to the mycobacteria that induced the disease. The immunosuppressive response was similar for both drugs: DXT, which is known to suppress the immune response, and ASA, a classical anti-inflammatory agent.
在人类类风湿性关节炎和佐剂性关节炎中,针对IgG和II型胶原蛋白产生抗体的方式相似。在本研究中,分析了地塞米松(DXT)和乙酰水杨酸(ASA)对抗体合成的影响。在诱导关节炎后第14天至第56天,每天口服DXT(0.3毫克/千克/天)或ASA(200毫克/千克/天),可抑制针对IgG和II型胶原蛋白的抗体合成,以及对诱发该疾病的分枝杆菌的体液免疫反应。两种药物的免疫抑制反应相似:已知能抑制免疫反应的DXT和经典抗炎药ASA。